好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

2022 Annual Meeting | S8 - General Neurology: Clinical Treatment and Practice

Sunday 04/03/22
03:30 PM - 05:30 PM PDT Add To Calendar
This program will be presented both in-person and online
This program will be available in the meeting's On Demand product.
Scientific Platform Session
Christopher B. Ransom, MD, PhD, Maxwell T. Ma, MD
General Neurology
2.00 CME credits

Program Materials Program Evaluations

Event Timeline
03:30 PM - 03:30 PM PDT Speaker walk in slides
Erin Jackson
03:30 PM - 03:42 PM PDT Abstract 001 - Clinical Diversity of Patients with Neuronal Intranuclear Inclusion Disease
Tomoko Okamoto
03:42 PM - 03:54 PM PDT Abstract 002 - Cipaglucosidase alfa/miglustat Versus alglucosidase alfa/placebo in Late-onset Pompe Disease (LOPD): PROPEL Study Subgroup Analyses
Tahseen Mozaffar, MD, FAAN
03:54 PM - 04:06 PM PDT Abstract 003 - HELIOS-A: Results from the Phase 3 Study of Vutrisiran in Patients with Hereditary Transthyretin-Mediated Amyloidosis with Polyneuropathy
Michael J. Polydefkis, MD, FAAN
04:06 PM - 04:18 PM PDT Abstract 004 - Virtual vs In-person Neurological Exam Study (VINES) in Response to the COVID-19 Crisis and Beyond
Lauren Hophing, MD
04:18 PM - 04:30 PM PDT Abstract 005 - VA National TeleNeurology Program: Patient Characteristics and Access to Care
Steven S. Schreiber, MD
04:30 PM - 04:42 PM PDT Abstract 006 - Differential Associations of Kidney Function with Cerebral Gray and White Matter Tissue Health in Middle-Aged and Older Adults
Mei-jun Shu
04:42 PM - 04:54 PM PDT Abstract 007 - Longitudinal Evaluation of Neuro-PASC Symptoms
Andrew Valenciano, MD
05:06 PM - 05:18 PM PDT Abstract 009 - A Placebo-Controlled Phase I Study of NVG-291 in Healthy Subjects, Targeting CNS Receptor Protein Tyrosine Phosphatase Sigma (PTPs)
Daniel D. Mikol, MD, PhD
05:18 PM - 05:30 PM PDT Abstract 010 - Neutralizing Antibody Conversion With Onabotulinumtoxina From Global Studies Across Multiple Indications In Nearly 30,000 Patient Records: A Meta-Analysis
Mitchell F. Brin, MD, FAAN
Faculty Disclosures
John L. Berk John L. Berk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alnylam Pharmaceuticals. John L. Berk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ionis Pharmaceuticals. John L. Berk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astra Zeneca/IONIS. John L. Berk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eidos/BridgBio. John L. Berk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Intellia Therapeutics. John L. Berk has received research support from Alnylam . John L. Berk has received research support from Ionis. John L. Berk has received research support from Eidos/Bridgbio.
No disclosure on file
Laura Piera Obici No disclosure on file
Jun Ni Jun Ni has nothing to disclose.
Michael J. Polydefkis, MD, FAAN Dr. Polydefkis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alnylam Pharmaceuticals. Dr. Polydefkis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Akcea. Dr. Polydefkis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vertex Pharmaceutical . Dr. Polydefkis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen-Idec. Dr. Polydefkis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer.
Sara B. Mitchell, MD Dr. Mitchell has nothing to disclose.
Yuji Takahashi, MD, PhD The institution of Dr. Takahashi has received research support from Nihon Medi-Physics Co. Limit.. The institution of Dr. Takahashi has received research support from Takeda Pharmaceutical Company Limited.
Zheng-Yu Jin No disclosure on file
Daniel D. Mikol, MD, PhD Dr. Mikol has received personal compensation for serving as an employee of NervGen. Dr. Mikol has received personal compensation for serving as an employee of Amgen. Dr. Mikol has received personal compensation in the range of $100,000-$499,999 for serving as an officer or member of the Board of Directors for NervGen. Dr. Mikol has stock in NervGen. Dr. Mikol has stock in Amgen. Dr. Mikol has received personal compensation in the range of $100,000-$499,999 for serving as a Employee with NervGen.
Andrew Valenciano, MD Dr. Valenciano has nothing to disclose.
Yuji Saitoh, MD, FAAN Dr. Saitoh has received stock or an ownership interest from Meiji Holdings Co. Ltd.. Dr. Saitoh has received stock or an ownership interest from Daiichi Sankyo Co. Ltd.. Dr. Saitoh has received stock or an ownership interest from Japan Tobacco Inc.. Dr. Saitoh has received stock or an ownership interest from Otsuka Holdings Co., Ltd.. Dr. Saitoh has received stock or an ownership interest from Fujifilm Holdings Corporation. Dr. Saitoh has received stock or an ownership interest from Johnson & Johnson. Dr. Saitoh has received stock or an ownership interest from 3M Company. The institution of Dr. Saitoh has received research support from Japan Agency for Medical Research and Development (AMED). Dr. Saitoh has received publishing royalties from a publication relating to health care. Dr. Saitoh has received publishing royalties from a publication relating to health care. Dr. Saitoh has received publishing royalties from a publication relating to health care.
Holly Martin No disclosure on file
Markus Naumann, MD No disclosure on file
Tomoko Okamoto Tomoko Okamoto has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Novartis. The institution of Tomoko Okamoto has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Takeda Pharma. Tomoko Okamoto has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Biogen. The institution of Tomoko Okamoto has received research support from EA Pharma Co., Ltd. The institution of Tomoko Okamoto has received research support from Sanofi. The institution of Tomoko Okamoto has received research support from Novartis. Tomoko Okamoto has received intellectual property interests from a discovery or technology relating to health care.
Garrett M. Timmons, MD Dr. Timmons has nothing to disclose.
Tahseen Mozaffar, MD, FAAN Dr. Mozaffar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion Pharmaceuticals. Dr. Mozaffar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Argenx. Dr. Mozaffar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Mozaffar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amicus. Dr. Mozaffar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Grifols. Dr. Mozaffar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Astellas Gene Therapy. Dr. Mozaffar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bayer. Dr. Mozaffar has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Mozaffar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Applied Therapeutics. The institution of Dr. Mozaffar has received research support from NIH. The institution of Dr. Mozaffar has received research support from Muscular Dystrophy Association. The institution of Dr. Mozaffar has received research support from Sanofi. The institution of Dr. Mozaffar has received research support from Argenx. The institution of Dr. Mozaffar has received research support from Amicus Therapeutics. The institution of Dr. Mozaffar has received research support from Astellas Gene Therpay. The institution of Dr. Mozaffar has received research support from Cartesian. The institution of Dr. Mozaffar has received research support from Cabaletta. Dr. Mozaffar has received personal compensation in the range of $500-$4,999 for serving as a Study Section Member with NIH.
Naomichi Matsumoto No disclosure on file
Dilraj S. Sokhi, FRCP Dr. Sokhi has nothing to disclose.
Antonio Toscano, MD Dr. Toscano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Genzyme.
Yoshiki Sekijima, MD, PhD Yoshiki Sekijima, "MD, PhD" has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alnylam. Yoshiki Sekijima, "MD, PhD" has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Pfizer.
Fei Han Fei Han has nothing to disclose.
Jacqueline Shanley, CRC Miss Shanley has nothing to disclose.
Linda S. Williams, MD, FAAN The institution of Dr. Williams has received research support from VA HSR&D.
Joseph Jankovic, MD, FAAN Dr. Jankovic has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Revance. Dr. Jankovic has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Revance, Allergan. The institution of Dr. Jankovic has received research support from Baylor College of Medicine. Dr. Jankovic has received research support from Abbvie. The institution of Dr. Jankovic has received research support from Abbvie.
Maria Alejandra Gonzalez Duarte, MD, FAAN Dr. Gonzalez Duarte has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alnylam. Dr. Gonzalez Duarte has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astra Zeneca. Dr. Gonzalez Duarte has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alnylam . The institution of Dr. Gonzalez Duarte has received research support from Pfizer.
Jayne R. Wilkinson, MD, MSCE Dr. Wilkinson has nothing to disclose.
Toshiyuki Yamamoto Dr. Yamamoto has nothing to disclose.
Yi-Cheng Zhu, MD, PhD Dr. Zhu has nothing to disclose.
Mitchell F. Brin, MD, FAAN Dr. Brin has received personal compensation for serving as an employee of Allergan. Dr. Brin has stock in Allergan.
Violaine Plante-Bordeneuve, MD Dr. Plante-Bordeneuve has nothing to disclose.
Priya Kishnani, MD Priya Kishnani, MD has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi/Genzyme. Priya Kishnani, MD has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amicus Therapeutics. Priya Kishnani, MD has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Maze Therapeutics. Priya Kishnani, MD has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for JCR Pharmaceutical. Priya Kishnani, MD has received personal compensation in the range of $500,000-$999,999 for serving as a Consultant for Asklepios Biopharmaceutical Inc. (AskBio). Priya Kishnani, MD has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi/Genzyme. Priya Kishnani, MD has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Amicus Therapeutics. Priya Kishnani, MD has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Baebies, Inc.. The institution of Priya Kishnani, MD has received research support from Sanofi/Genzyme. Priya Kishnani, MD has received research support from Amicus Therapeutics. Priya Kishnani, MD has received intellectual property interests from a discovery or technology relating to health care. Priya Kishnani, MD has received intellectual property interests from a discovery or technology relating to health care.
Rita Singh, PharmD Dr. Singh has received personal compensation for serving as an employee of AbbVie. Dr. Singh has stock in AbbVie.
Drago Bratkovic No disclosure on file
Teresa Coelho, MD Dr. Coelho has nothing to disclose.
Benedikt Schoser Benedikt Schoser has received personal compensation for serving as an employee of Alexion. Benedikt Schoser has received personal compensation for serving as an employee of Argenx. Benedikt Schoser has received personal compensation for serving as an employee of Amicus. Benedikt Schoser has received personal compensation for serving as an employee of Astellas. Benedikt Schoser has received personal compensation for serving as an employee of Denali. Benedikt Schoser has received personal compensation for serving as an employee of Avidity . Benedikt Schoser has received personal compensation for serving as an employee of Sanofi. Benedikt Schoser has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Taysha. Benedikt Schoser has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Astellas. Benedikt Schoser has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Encoded. Benedikt Schoser has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Kedrion.
Visesha Kakarla Miss Kakarla has nothing to disclose.
Shu-Yang Zhang No disclosure on file
John Vest John Vest has received personal compensation for serving as an employee of Alnylam Pharmaceuticals. John Vest has received stock or an ownership interest from Alnylam Pharmaceuticals. John Vest has received intellectual property interests from a discovery or technology relating to health care.
Seth Arum Seth Arum has received personal compensation for serving as an employee of Alnylam Pharmaceuticals. Seth Arum has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wolters Kluwer.
Barry Byrne Barry Byrne has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. Barry Byrne has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Rocket Pharma. Barry Byrne has received personal compensation in the range of $5,000-$9,999 for serving as an officer or member of the Board of Directors for Muscular Dystrophy Association.
Noriko Sato No disclosure on file
Steven S. Schreiber, MD Dr. Schreiber has nothing to disclose.
David D. Adams David D. Adams has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for ALNYLAM. David D. Adams has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer.
Aditi Narechania, MD Dr. Narechania has nothing to disclose.
Mei-jun Shu Mei-jun Shu has nothing to disclose.
Ding-Ding Zhang Ding-Ding Zhang has nothing to disclose.
Ans Van Der Ploeg The institution of Ans Van Der Ploeg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi Genzyme . The institution of Ans Van Der Ploeg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amicus. The institution of Ans Van Der Ploeg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Spark Therapeutics . The institution of Ans Van Der Ploeg has received research support from Sanofi Genzyme.
Mark Roberts Mark Roberts has nothing to disclose.
Ming Yao Ming Yao has nothing to disclose.
Lauren Hophing, MD Dr. Hophing has nothing to disclose.
Jeff Castelli No disclosure on file
Pascal Lafort No disclosure on file
Houman Khosravani, MD, PhD Dr. Khosravani has nothing to disclose.
Torge Rempe, MD Dr. Rempe has nothing to disclose.
Fazal Yakub Fazal Yakub has nothing to disclose.
Li-Ying Cui No disclosure on file
Charles Kassardjian, MD Dr. Kassardjian has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Genzyme. Dr. Kassardjian has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Kassardjian has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Kassardjian has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Kassardjian has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Astra Zeneca. Dr. Kassardjian has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Kassardjian has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Argenx.
Jennifer Graves, MD, PhD Dr. Graves has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Graves has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Graves has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MSJ. The institution of Dr. Graves has received research support from Octave. The institution of Dr. Graves has received research support from Sanofi. The institution of Dr. Graves has received research support from EMD Serono.
Christopher B. Ransom, MD, PhD The institution of Dr. Ransom has received research support from Dept of Veterans Affairs, BLR&D.
Maxwell T. Ma, MD Dr. Ma has nothing to disclose.
Erin Jackson Ms. Jackson has nothing to disclose.